| Issue Date | Title | Author(s) |
| 2020-12 | Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. | Zhu, D; Chung, H-F; Dobson, AJ; Pandeya, N; Anderson, DJ; Kuh, D; Hardy, R; Brunner, EJ; Avis, NE; Gold, EB; El Khoudary, SR; Crawford, SL; Mishra, GD |
| 2016-06-14 | A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis | Teasdale, SB; Ward, PB; Rosenbaum, S; Watkins, A; Curtis, J; Kalucy, M; Samaras, K |
| 2022-02 | Cardiovascular risk prediction in healthy older people. | Neumann, JT; Thao, LTP; Callander, E; Chowdhury, E; Williamson, JD; Nelson, MR; Donnan, G; Woods, RL; Reid, CM; Poppe, KK; Jackson, R; Tonkin, AM; McNeil, JJ |
| 2022-09-24 | Older peoples' views on cardiovascular disease medication: a qualitative study. | Wallis, KA; Taylor, DA; Fanueli, EF; Saravanakumar, P; Wells, S |
| 2021-04-26 | An electronic decision support‐based complex intervention to improve management of cardiovascular risk in primary health care: a cluster randomised trial (INTEGRATE) | Webster, R; Usherwood, T; Joshi, R; Saini, B; Armour, C; Critchley, S; Di Tanna, GL; Galgey, S; Hespe, CM; Jan, S; Karia, A; Kaur, B; Krass, I; Laba, T; Li, Q; Lo, S; Peiris, DP; Reid, C; Rodgers, A; Shiel, L; Strathdee, J; Zamora, N; Patel, A |
| 2021-05-05 | Community Group-Based Models of Medication Delivery: Applicability to Cardiovascular Diseases. | Kwon, C; Webster, R; Santo, K; Atkins, E |
| 2021-11 | Patient perspectives and experiences of sexual health conversations and cardiovascular disease: A qualitative study. | East, L; Jackson, D; Manias, E; Dunning, T; Hutchinson, M |
| 2021-10 | Cardiovascular disease risk prediction in older people: a qualitative study. | Taylor, DA; Wallis, KA; Feki, S; Moala, SS; Latu, M; Fanueli, EF; Saravanakumar, P; Wells, S |
| 2017-07 | [Cost effectiveness of GnRH antagonists in patients with prostate cancer and cardiovascular risk : Comparative analysis against Leuprorelin by the Number Needed to Treat]. | Anderson, D; Lehmann, J; Ecker, T; Vosgerau, S; Donatz, V |
| 2018-07-01 | Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial. | Singh, K; Crossan, C; Laba, T-L; Roy, A; Hayes, A; Salam, A; Jan, S; Lord, J; Tandon, N; Rodgers, A; Patel, A; Thom, S; Prabhakaran, D |
